NEW BRUNSWICK (dpa-AFX) – Johnson & Johnson (JNJ) on Monday announced a definitive agreement to acquire Firefly Bio, Inc., a biotechnology company for $1 billion in cash.The transaction is expecte…
Johnson & Johnson To Acquire Firefly Bio To Expand Oncology Pipeline
Source: Finanznachrichten.de
Read Full Story →
